A New Clinical Trial Just Made Diabetes Patients Insulin Independent
New research involving pancreatic islet cell implants show promise in treating Type 1 Diabetes, a potentially debilitating form of the disease that affects more than a million people in the U.S. This new treatment might just spell the end for T1D.
With Promising Potential
No matter how modern the world has become, there are certain ailments that continue to persist. One of these is diabetes, and according to the World Health Organization (WHO), there are now over 422 million people in the world suffering from it. Generally characterized as a problem in blood sugar levels, diabetes has two variants — an insulin-dependent one, known as type 1 diabetes (T1D), and type 2 diabetes that’s non-insulin-dependent.
In the United States, the Juvenile Diabetes Research Foundation reports that about 1.25 million people have T1D. The cause of this particular diabetes variant still remains unknown, and treatments generally involve pumping insulin daily into the patient’s body. As such, there’s still no known cure for T1D. However, researchers from the University of Miami Leonard M. Miller School of Medicine in Florida may have just made it possible to develop one.
In a study published in the New England Journal of Medicine, the researchers described how clinical trials involving pancreatic islet cell implants to the omentum — the tissue covering organs in the abdomen — shows promise in treating T1D. “Islet transplantation can restore euglycemia and eliminate severe hypoglycemia in patients with [T1D],” the researchers wrote. “The omentum has a dense vascularized surface Continue reading